Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Choueiri, T. K.; Albiges, L.; Haanen, J. B. A. G.; Larkin, J. M. G.; Uemura, M.; Pal, S. K.; Gravis, G.; Campbell, M. T.; Penkov, K.; Lee, J. L.; Ching, K. A.; Mu, X. J.; Wang, X.; Zhang, W.; Wang, J.; Chudnovsky, A.; di Pietro, A.; Robbins, P. B.; Motzer, R. J. |
| Abstract Title: | Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 6s |
| Language: | English |
| ACCESSION: | WOS:000487345803486 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.101 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 101 -- Source: Wos |
